← All trials
NCT04439721
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2020
- Primary completion
- May 1, 2021
- Completion date
- May 1, 2021
- First posted
- Jun 19, 2020
- Last posted
- Jun 19, 2020
- Enrollment
- 5
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.Lead sponsor
- Soochow UniversityCollaborator
- Soochow UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.